Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$419K Buy
7,994
+3,446
+76% +$182K 0.01% 708
2026
Q1
$251K Sell
4,548
-3,354
-42% -$182K 0.01% 650
2025
Q4
$387K Buy
7,902
+101
+1% +$4.71K 0.02% 490
2025
Q3
$337K Buy
+7,801
New +$305K 0.02% 532

Other funds holding GSK

Simplicity Wealth's GSK Position: Q2 2026 in Review

Simplicity Wealth increased its GSK (GSK) stake by 76% in Q2 2026, buying an estimated $182K and bringing the position to 7,994 shares worth $419K. The position accounts for 0.01% of the portfolio, ranked #708.

Simplicity Wealth first reported a position in GSK in Q3 2025 and has held it in 4 quarters since. 1,040 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Simplicity Wealth held 7,994 shares of GSK worth $419K as of Q2 2026.
  • Simplicity Wealth bought 3,446 GSK shares in Q2 2026, an estimated $182K.
  • GSK made up 0.01% of Simplicity Wealth's portfolio in Q2 2026, its #708 holding.
  • Simplicity Wealth first reported a position in GSK in Q3 2025 and has held it in 4 quarters since.
  • 1,040 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Simplicity Wealth's 13F filing for Q2 2026, filed 6 Aug 2026.